JAN 15, 2020 12:38 PM PST

A New Drug Target for Substance Abuse

WRITTEN BY: Nouran Amin

Research carried out by the University of Minnesota Medical School indicates a new drug target for treating a drug addiction. Researchers note that the drug is finding "the hidden stars of the brain." The study was published in Neuron and indicates that targeting the calcium signaling of the star shaped neural supporting cell ‘astrocyte’ could decrease the behavioral effects of drug abuse.

"These findings suggest that astrocytes contribute to amphetamine signaling, dopamine signaling and overall reward signaling in the brain," says Michelle Corkrum said. "Because of this, astrocytes are a potentially novel cell type that can be specifically targeted to develop efficacious therapies for diseases with dysregulated dopamine."

One form of drug abuse comes from amphetamine as a result of dopamine disruption. Dopamine is one of the major molecules in the brain that contribute to learning and memory as well as motivated behaviors. It is believed that when dopamine is disrupted, that is when individuals are more prone to substance abuse, and in that case—amphetamine.

Learn more about substance use disorders:

In the study, astrocytes were found to respond to dopamine when calcium is increased in a region of the brain known as the nucleus accumbens—which is one the major reward centers of the brain. The increase of calcium was correlated with the release of ATP/adenosine to modulate neural activity in the nucleus accumbens.

They also found that amphetamine causes astrocytes to respond when calcium is increased.

"We were able to integrate the phenomenal resources that the U of M offers to conduct state-of-the-art research and work with numerous different core facilities, which played key roles in this study," Corkrum said.

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JUL 02, 2020
Cannabis Sciences
What is the Difference Between CBD and CBG?
JUL 02, 2020
What is the Difference Between CBD and CBG?
Like cannabidiol (CBD), cannabigerol (CBG) is a cannabinoid. Both compounds are found in cannabis plants. Both are also ...
JUL 05, 2020
Drug Discovery & Development
New Drug May Reduce Inflammation from COVID-19
JUL 05, 2020
New Drug May Reduce Inflammation from COVID-19
Scientists from the University of Toronto have identified a new drug candidate that may reduce all kinds of inflammation ...
JUL 20, 2020
Neuroscience
Phantom-Limb Pain Reduced by Brain-Computer Interface
JUL 20, 2020
Phantom-Limb Pain Reduced by Brain-Computer Interface
Phantom-limb pain is a condition in which amputees feel like their amputated limb is still attached to their bodies. Whi ...
JUL 23, 2020
Cardiology
Protecting the Heart After a Heart Attack
JUL 23, 2020
Protecting the Heart After a Heart Attack
Cardiovascular disease accounts for thirty percent of mortalities around the world. These diseases start small and slowl ...
JUL 02, 2020
Drug Discovery & Development
Electrochemicals Fuel The Path for Drug Discovery
JUL 02, 2020
Electrochemicals Fuel The Path for Drug Discovery
Drug discovery scientists at Cornell University have diverted away from the traditional synthetic chemistry into a more ...
JUL 30, 2020
Immunology
Gene Silencing Therapy Stops the Itch of Psoriasis
JUL 30, 2020
Gene Silencing Therapy Stops the Itch of Psoriasis
A team of Harvard researchers has identified a promising new approach for treating psoriasis — a topical lotion co ...
Loading Comments...